Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2015

01-09-2015 | Letter to the Editor

Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report

Authors: Alessandro Lucchesi, Pier Paolo Fattori, Sonia Ronconi, Silvia Carloni, Andrea Casadei Gardini, Gerardo Musuraca, Mariasanta Napolitano

Published in: Annals of Hematology | Issue 9/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Chapman K, Seldon M, Richards R (2012) Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Semin Thromb Hemost 38:47–54PubMedCrossRef
3.
Scully M, Hunt BJ, Benjamin S, Licenser R, Rose P, Peyvandi F, Cheung B, Machin SJ (2012) British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158:323–335PubMedCrossRef
4.
Stein GY, Zeidman A, Fradin Z, Varon M, Cohen A, Mittelman M (2004) Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide. Int J Hematol 80:94–96PubMedCrossRef
5.
Imanirad I, Rajasekhar A, Zumberg M (2012) A case series of atypical presentations of thrombotic thrombocytopenic purpura. J Clin Apher 27:221–226PubMedCrossRef
6.
Idowu M, Reddy P (2013) Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke. Am J Hematol 88:237–239PubMedCrossRef
7.
Sarode R (2009) Atypical presentations of thrombotic thrombocytopenic purpura: a review. J Clin Apher 24:47–52PubMedCrossRef
8.
Downes KA, Yomtovian R, Tsai HM, Silver B, Rutherford C, Sarode R (2004) Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident. J Clin Apher 19(2):86–89PubMedCrossRef
9.
Tsai HM, Shulman K (2003) Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Haematol 70(3):183–185PubMedCrossRef
10.
O’Brien TE, Crum ED (2002) Atypical presentations of thrombotic thrombocytopenic purpura. Int J Hematol 76(5):471–473PubMedCrossRef
Metadata
Title
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report
Authors
Alessandro Lucchesi
Pier Paolo Fattori
Sonia Ronconi
Silvia Carloni
Andrea Casadei Gardini
Gerardo Musuraca
Mariasanta Napolitano
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-015-2415-y

Other articles of this Issue 9/2015

Annals of Hematology 9/2015 Go to the issue

Letter to the Editor

Negative PET: no guarantee of good prognosis in Hodgkin’s lymphoma

Original Article

High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type

Letter to the Editor

Analysis of survival by tumor response: have we learnt any better?

Original Article

Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT

Original Article

HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia

Original Article

Hospital population screening reveals overrepresentation of CD5− monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits